{
    "clinical_study": {
        "@rank": "78858", 
        "arm_group": [
            {
                "arm_group_label": "Lean Adolescents", 
                "description": "Kids aged 12-17 with body mass index less than 25% and normal glucose tolerance test results"
            }, 
            {
                "arm_group_label": "Obese Insulin Sensitive", 
                "description": "Obese Insulin Sensitive Adolescents aged 12-17 with BMI>95th% and whole body insulin sensitivity index > 3."
            }, 
            {
                "arm_group_label": "Obese Insulin Resistant Adolscent", 
                "description": "Obese Insulin Resistant Adolescents 12-17 with BMI> 95th% and WBISI<1.2."
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "To explore whether obese adolescents with insulin resistance and relative low leptin levels\n      exhibit functional alterations of the neuronal circuits involved in the regulation of energy\n      metabolism and food seeking behaviors.\n\n      We here propose to test the hypothesis that the reward circuitry is dysregulated in obese\n      adolescents and is related to the degree of insulin resistance and hyperinsulinemia."
        }, 
        "brief_title": "Neural Functioning of Feeding Centers in Obese Youth", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Insulin Resistance"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Insulin Resistance", 
                "Obesity"
            ]
        }, 
        "detailed_description": {
            "textblock": "Functional Magnetic Resonance Imaging (fMRI) provides a non-invasive method to assess the\n      functional pathways affected by nutrient ingestion and therefore can help answer important\n      questions regarding potential differences in the response of brain regions involved in\n      feeding."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Obese adolescents\n\n          -  Good general health,\n\n          -  taking no medication on a chronic basis\n\n          -  Age 12 to 17 yrs,\n\n          -  in puberty (girls and boys: Tanner stage II - IV)\n\n        Obese Insulin Resistant Adolescents\n\n          -  (BMI> 95th)\n\n          -  (WBISI<1.2 plus a low adiponectin <6 ug/dl and\n\n          -  high triglyceride levels >130mg/dl)\n\n        Obese Insulin Sensitive Adolescents\n\n          -  (BMI>95th)\n\n          -  (WBISI >3) plus high adiponectin >8 ug/ml and\n\n          -  triglyceride levels > 80 mg/dl Girls who begin menstruating must have a negative\n             pregnancy test during the study\n\n        Eligibility criteria for healthy non-obese children and adolescents:\n\n          -  Brother or sister with obesity\n\n          -  Age 12 to 17 years\n\n          -  Normal fasting glucose and lipids in the child, and\n\n          -  normal OGTT\n\n          -  No use of any medication known to affect glucose, lipid metabolism and inflammation\n\n          -  No endocrinopathies\n\n          -  No use of any antipsychotic medication\n\n          -  BMI >25th to <75th ( Center for Disease Control (CDC) BMI Charts)\n\n          -  Minimum weight of 90lbs (CDC Growth Charts)\n\n        Exclusion Criteria\n\n          -  Baseline creatinine >1.0 mg\n\n          -  Pregnancy\n\n          -  Presence of endocrinopathies (e.g. Cushing syndrome)\n\n          -  Cardiac or pulmonary or other significant chronic illness\n\n          -  Adolescents with psychiatric disorder or with substance abuse determined via\n             self-report.\n\n          -  Use of anorexic agents No metal implants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "12 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Clinic patients of Dr. Caprio at the Yale Pediatric Obesity Clinic who have undergone oral\n        glucose tolerance testing (OGTT) and found to be insulin resistant or sensitive and/or\n        previous research subjects who were found to be insulin resistant or sensitive and who\n        agreed to be contacted for other studies will be contacted."
            }
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01808846", 
            "org_study_id": "1001006251", 
            "secondary_id": "R01DK085577"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity", 
            "Insulin Resistance", 
            "functional magnetic resonance imaging", 
            "glucose", 
            "fructose", 
            "hypothalamus", 
            "neuronal circuits", 
            "feeding behavior"
        ], 
        "lastchanged_date": "October 17, 2013", 
        "location": {
            "contact": {
                "last_name": "Bridget Pierpont, M.A.", 
                "phone": "203-785-2942"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06510"
                }, 
                "name": "Yale University"
            }, 
            "investigator": {
                "last_name": "Sonia Caprio, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Neural Functioning of Feeding Centers in Obese Youth", 
        "other_outcome": {
            "measure": "fMRI measure of BOLD signal brain reactivity to food cues", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 2 year follow up"
        }, 
        "overall_contact": {
            "last_name": "Bridget Pierpont, M.A.", 
            "phone": "203-785-2942"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Sonia Caprio, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "fMRI measure of cerebral blood flow response to glucose ingestion", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 2 year follow up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01808846"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Sonia Caprio", 
            "investigator_title": "Professor of Pediatrics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "fMRI measure of cerebral blood flow response to fructose ingestion", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 2 year follow up"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}